195 related articles for article (PubMed ID: 10144214)
1. Disease management: opportunity for pharmaceutical care?
Woodward BW
Hosp Pharm; 1995 Jul; 30(7):596, 599-603, 606-8. PubMed ID: 10144214
[TBL] [Abstract][Full Text] [Related]
2. Disease management: partnering for better patient care.
Sylvestri MF; Marro EP
Med Interface; 1996 Jul; 9(7):100-4. PubMed ID: 10159274
[TBL] [Abstract][Full Text] [Related]
3. Implications of disease management in the future of managed care.
Zalta E; Eichner H; Henry M
Med Interface; 1994 Dec; 7(12):66-9, 78. PubMed ID: 10139403
[TBL] [Abstract][Full Text] [Related]
4. Patient consultation in a managed care setting: guiding pharmacy into the future.
Foster SL; Smith EB
Am J Manag Care; 1998 Jul; 4(7):1039-46; quiz 1047-8. PubMed ID: 10181993
[TBL] [Abstract][Full Text] [Related]
5. A benefit-based copay for prescription drugs: patient contribution based on total benefits, not drug acquisition cost.
Fendrick AM; Smith DG; Chernew ME; Shah SN
Am J Manag Care; 2001 Sep; 7(9):861-7. PubMed ID: 11570020
[TBL] [Abstract][Full Text] [Related]
6. Pharmaceutical industry overview: optimal drug therapy.
Blake P
Can J Clin Pharmacol; 2001; 8 Suppl A():48A-52A. PubMed ID: 11586380
[TBL] [Abstract][Full Text] [Related]
7. Disease management. Putting the pieces together.
Bazzoli F
Health Data Manag; 1996 Jan; 4(1):28-32, 34, 36-7. PubMed ID: 10154354
[TBL] [Abstract][Full Text] [Related]
8. A commentary on high-cost drugs.
de Leon RF
Curr Concepts Hosp Pharm Manage; 1989; 11(3):4-7. PubMed ID: 10318277
[TBL] [Abstract][Full Text] [Related]
9. The emerging role of psychiatric pharmacists.
Cohen LJ
Am J Manag Care; 1999 Jul; 5(10 Suppl):S621-9; quiz S630-3. PubMed ID: 10539497
[TBL] [Abstract][Full Text] [Related]
10. [Pharmaceutical care of patients with diabetes mellitus and its relationship to clinical pharmacy].
Vlcek J; Malý J; Dosedel M
Vnitr Lek; 2009 Apr; 55(4):384-8. PubMed ID: 19449755
[TBL] [Abstract][Full Text] [Related]
11. Disease management broadens focus of care from episodic to long-range.
Southwick K
Strateg Healthc Excell; 1995 Jun; 8(6):1-9. PubMed ID: 10142933
[No Abstract] [Full Text] [Related]
12. Reframing the pharmaceutical manufacturer/health plan relationship in managed care.
Studin I
Manag Care; 2002 Feb; 11(2):46, 49-54. PubMed ID: 11904913
[TBL] [Abstract][Full Text] [Related]
13. Pharmaceutical care: pharmacy's mission for the 1990s.
Penna RP
Am J Hosp Pharm; 1990 Mar; 47(3):543-9. PubMed ID: 2316539
[TBL] [Abstract][Full Text] [Related]
14. Battered bottom lines: the impact of eroding pharmaceutical discounts on health-care institutions.
Palumbo FB; Schondelmeyer SW; Miller DW; Speedie SM
Am J Hosp Pharm; 1992 May; 49(5):1177-85. PubMed ID: 1595750
[TBL] [Abstract][Full Text] [Related]
15. Facing the next challenge of pharmaceutical care: patient noncompliance.
Bloom DL
Med Interface; 1996 Nov; 9(11):67-72. PubMed ID: 10162562
[TBL] [Abstract][Full Text] [Related]
16. Specialty pharmaceuticals: developing a management plan.
Willcutts D
Manag Care Q; 2002; 10(4):26-9. PubMed ID: 12561391
[TBL] [Abstract][Full Text] [Related]
17. Dialogue. Prescription for problems? Capitating mental health drugs--the great debate.
Docherty JP; Browne RA; Farmer M
Behav Healthc Tomorrow; 1998 Oct; 7(5):32-8. PubMed ID: 10185199
[TBL] [Abstract][Full Text] [Related]
18. Managing prescription drug costs.
Sica JM
Empl Benefits J; 2001 Mar; 26(1):35-40. PubMed ID: 11272515
[TBL] [Abstract][Full Text] [Related]
19. Pharmacoeconomics: therapeutic and economic considerations in treating the critically ill patient.
Crane VS
DICP; 1990 Nov; 24(11 Suppl):S24-7. PubMed ID: 2125394
[TBL] [Abstract][Full Text] [Related]
20. American Society of Clinical Oncology guidance statement: the cost of cancer care.
Meropol NJ; Schrag D; Smith TJ; Mulvey TM; Langdon RM; Blum D; Ubel PA; Schnipper LE;
J Clin Oncol; 2009 Aug; 27(23):3868-74. PubMed ID: 19581533
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
